Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 9

Results: 10

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 848, doi. 10.1002/cac2.12341
By:
- Dai, Weixing;
- Xiang, Wenqiang;
- Han, Lingyu;
- Yuan, Zixu;
- Wang, Renjie;
- Ma, Yanlei;
- Yang, Yongzhi;
- Cai, Sanjun;
- Xu, Ye;
- Mo, Shaobo;
- Li, Qingguo;
- Cai, Guoxiang
Publication type:
Article
Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 801, doi. 10.1002/cac2.12339
By:
- Poh, Sharon S;
- Wee, Joseph TS
Publication type:
Article
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 868, doi. 10.1002/cac2.12334
By:
- Yuan, Ye;
- Wang, Li‐Hong;
- Zhao, Xian‐Xian;
- Wang, Jiao;
- Zhang, Meng‐Si;
- Ma, Qing‐Hua;
- Wei, Sen;
- Yan, Ze‐Xuan;
- Cheng, Yue;
- Chen, Xiao‐Qing;
- Zou, Hong‐Bo;
- Ge, Jia;
- Wang, Yan;
- Zhang, Xia;
- Cui, You‐Hong;
- Luo, Tao;
- Bian, Xiu‐Wu
Publication type:
Article
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 897, doi. 10.1002/cac2.12331
By:
- Fajardo, Pilar;
- Taskova, Maria;
- Martín‐Serrano, Miguel A.;
- Hansen, Jonas;
- Slott, Sofie;
- Jakobsen, Anna K.;
- Wibom, Marie‐Louise;
- Salegi, Beñat;
- Muñoz, Alberto;
- Barbachano, Antonio;
- Sharma, Arpita;
- Gubatan, John Mark;
- Habtezion, Aida;
- Sanz‐Ezquerro, Juan J.;
- Astakhova, Kira;
- Cuenda, Ana
Publication type:
Article
Antibody variable region engineering for improving cancer immunotherapy.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 804, doi. 10.1002/cac2.12330
By:
- Lou, Hantao;
- Cao, Xuetao
Publication type:
Article
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 828, doi. 10.1002/cac2.12327
By:
- Liu, Chengming;
- Zheng, Sufei;
- Wang, Zhanyu;
- Wang, Sihui;
- Wang, Xinfeng;
- Yang, Lu;
- Xu, Haiyan;
- Cao, Zheng;
- Feng, Xiaoli;
- Xue, Qi;
- Wang, Yan;
- Sun, Nan;
- He, Jie
Publication type:
Article
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 902, doi. 10.1002/cac2.12320
By:
- Xu, Yan;
- Song, Yanjun;
- Liu, Xiaoyan;
- Shi, Yuequan;
- Liu, Yingxian;
- Qian, Hao;
- Gao, Xiaoxing;
- Chen, Minjiang;
- Pan, Ruili;
- Zhao, Jing;
- Zhong, Wei;
- Wu, Wei;
- Wang, Mengzhao
Publication type:
Article
Transcriptome‐wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 887, doi. 10.1002/cac2.12317
By:
- He, Yong‐Qiao;
- Xue, Wen‐Qiong;
- Li, Dan‐Hua;
- Wang, Tong‐Min;
- Mai, Zhi‐Ming;
- Yang, Da‐Wei;
- Deng, Chang‐Mi;
- Liao, Ying;
- Zhang, Wen‐Li;
- Xiao, Ruo‐Wen;
- Luo, Luting;
- Diao, Hua;
- Tong, Xiating;
- Wu, Yanxia;
- Zhang, Jiang‐Bo;
- Zhou, Ting;
- Li, Xi‐Zhao;
- Zhang, Pei‐Fen;
- Zheng, Xiao‐Hui;
- Zhang, Shao‐Dan
Publication type:
Article
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 892, doi. 10.1002/cac2.12292
By:
- Vitale, Emanuele;
- Sauta, Elisabetta;
- Gugnoni, Mila;
- Torricelli, Federica;
- Manicardi, Veronica;
- Ciarrocchi, Alessia
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2022, v. 42, n. 9, p. 799, doi. 10.1002/cac2.12173
Publication type:
Article